Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,407 | -5,364 | -3,734 | -1,912 | -2,206 |
| Depreciation Amortization | 14 | 602 | 518 | 195 | 81 |
| Accounts payable and accrued liabilities | -134 | -128 | -104 | 129 | 323 |
| Other Working Capital | -354 | -521 | -743 | -488 | 102 |
| Other Operating Activity | 225 | -1,548 | -1,660 | -1,971 | -240 |
| Operating Cash Flow | $-1,656 | $-6,959 | $-5,723 | $-4,047 | $-1,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 6 | 2 | N/A | N/A |
| Purchase Sale Intangibles | N/A | 2,000 | 2,000 | 2,000 | N/A |
| Other Investing Activity | 0 | 2,000 | 1,999 | 2,000 | 0 |
| Investing Cash Flow | $0 | $2,006 | $2,001 | $2,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 4,726 | 3,001 | 3,000 | N/A |
| Other Financing Activity | -60 | -855 | -556 | -515 | 0 |
| Financing Cash Flow | $-60 | $3,871 | $2,445 | $2,485 | $0 |
| Beginning Cash Position | 5,943 | 7,025 | 7,025 | 7,025 | 7,025 |
| End Cash Position | 4,227 | 5,943 | 5,748 | 7,463 | 5,085 |
| Net Cash Flow | $-1,716 | $-1,082 | $-1,277 | $438 | $-1,940 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,656 | -6,959 | -5,723 | -4,047 | -1,940 |
| Capital Expenditure | N/A | -19 | N/A | -1 | -1 |
| Free Cash Flow | -1,656 | -6,978 | -5,723 | -4,048 | -1,941 |